Peritoneal Dialysis in Children

Living reference work entry

Abstract

In children with chronic kidney disease stage 5D peritoneal dialysis (PD) remains the dialysis modality most commonly prescribed, especially as automated PD. Nowadays it can be started from the first days of life on, and applied even to some preterm babies. This chapter gives an overview on PD membrane ultrastructure and function, on technical prerequistes of PD, on optimal PD prescription and on specific treatment targets and tools to monitor efficacy. It describes PD related infectious and noninfectious complications, long term peritoneal and systemic sequelae and current state of the art of how these can be mitigated or even be prevented.

Keywords

Peritoneal Dialysis Patient Residual Renal Function Peritoneal Membrane Encapsulate Peritoneal Sclerosis Chronic Peritoneal Dialysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Adam FU, Singan M, Ozelsancak R, Torun D, Ozdemir FN, Haberal M. Icodextrin-associated sterile peritonitis: a recent outbreak in Turkey. Perit Dial Int. 2007;27:598–9.PubMedGoogle Scholar
  2. 2.
    Ahlenstiel T, Pape L, Ehrich JH, Kuhlmann MK. Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant. 2010;25(10):3241–9.PubMedGoogle Scholar
  3. 3.
    Ahmad S. Peritoneal dialysis. In: Ahmad S, editor. Manual of clinical dialysis. London: Science Press; 1999. p. 65–8.Google Scholar
  4. 4.
    Albaramki J, Hodson EM, Craig JC, Webster AC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012;1:CD007857.PubMedGoogle Scholar
  5. 5.
    Amici G, Viglino G, Gandolfo C, Da Rin G, Bocci C, Cavalli PL. Compliance study in peritoneal dialysis using PD Adequest software. Perit Dial Int. 1996;16 Suppl 1:S176–8.PubMedGoogle Scholar
  6. 6.
    Amici G. Continuous tidal peritoneal dialysis. Prescription and power. In: Ronco C, Amici G, Feriani M, Virga G, editors. Automated peritoneal dialysis. Basel: Karger; 1999. p. 134–41.Google Scholar
  7. 7.
    Andreoli SP, Langefeld CD, Stadler S, Smith P, Sears A, West K. Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis. Pediatr Nephrol. 1993;7:543–7.PubMedGoogle Scholar
  8. 8.
    Andreoli SP, Leiser J, Warady BA, Schlichting L, Brewer ED, Watkins SL. Adverse effect of peritonitis on peritoneal membrane function in children on dialysis. Pediatr Nephrol. 1999;13:1–6.PubMedGoogle Scholar
  9. 9.
    Aoun B, Ulinski T, Sanjad S, Termos S, Dahrouj M, El zoobi B, Kalkas G, Fakhoury H, Schmitt CP. Chronic peritoneal dialysis (PD) in Lebanese children of families with low socioeconomic status. Perit Dial Int. 2015 1–2;35(1):93–96.Google Scholar
  10. 10.
    Aranda RA, Pecoits-Filho RFS, Romao Jr JE, Kakehashi E, Sabbaga E, Marcondes M, Habensur H. Kt/V in children on CAPD: how much is enough? Perit Dial Int. 1999;19:588–9.PubMedGoogle Scholar
  11. 11.
    Aroeira LS, Aguilera A, Sánchez-Tomero JA, Bajo MA, del Peso G, Jiménez-Heffernan JA, Selgas R, López-Cabrera M. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18(7):2004–13.PubMedGoogle Scholar
  12. 12.
    Auron A, Simon S, Andrews W, Jones L, Johnson S, Musharaf G, Warady BA. Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol. 2007;22:578–85.PubMedGoogle Scholar
  13. 13.
    Azocar M, Quiroz L, Delucchi A, Dinamarca H, Emilfork M, Cano F. The plasma permeability factor in nephrotic syndrome: indirect evidence in pediatric peritoneal dialysis. Perit Dial Int. 2012;32(4):437–43.PubMedCentralPubMedGoogle Scholar
  14. 14.
    Bakewell AB, Higgins RM, Edmuns ME. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int. 2002;61:239–48.PubMedGoogle Scholar
  15. 15.
    Bakkaloglu SA, Borzych D, Soo HAI, Serdaroglu E, Buscher R, Salas P, Patel H, Drodzd D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F. Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol. 2011;6(8):1926–33.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Bakkaloglu SA, Ekim M, Tümer N, Güngör A, Yilmaz S. Pleurodesis treatment with tetracycline in peritoneal dialysis-complicated hydrothorax. Pediatr Nephrol. 1999;13:637–8.PubMedGoogle Scholar
  17. 17.
    Bakkaloglu SA, Saygili A, Server L, Noyan A, Akman S, Ekim M, Aksu N, Doganay B, Yildiz N, Duzova A, Soylu A, Alpay H, Sonmez F, Civilibal M, Erdem S, Kardelen F. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPED) report. Nephrol Dial Transplant. 2009;24(11):3525–32.PubMedGoogle Scholar
  18. 18.
    Bakkaloglu SA. Non-infectious complications of peritoneal dialysis in children. In: Warady BA, Schaefer FS, Alexander SR, editors. Pediatric dialysis. New York: Springer; 2012. p. 257–71.Google Scholar
  19. 19.
    Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, Farrington K, Gallagher H, Harnett P, Krausze S, Steddon S. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24:3209–15.PubMedGoogle Scholar
  20. 20.
    Balfe JW, Irwin MA. Continuous ambulatory peritoneal dialysis in children. In: Legrain M, editor. Continuous ambulatory peritoneal dialysis. Amsterdam: Excerpta Medica; 1980.Google Scholar
  21. 21.
    Bammens B, Evenpoel P, Verbecke K, Vanrenterghem Y. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int. 2003;64:2238–43.PubMedGoogle Scholar
  22. 22.
    Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–62.PubMedGoogle Scholar
  23. 23.
    Bargman JM. Slouching towards Bethlehem: the beast of biocompatibility. Nephrol Dial Transplant. 2010;25(7):2050–1.PubMedGoogle Scholar
  24. 24.
    Becker N, Brandt JR, Sutherland TA, Avner ED, Watkins SL. Improved outcome of young children on nightly automated peritoneal dialysis. Pediatr Nephrol. 1997;11:676–9.PubMedGoogle Scholar
  25. 25.
    Bender TO, Witowski J, Aufricht C, Endemann M, Frei U, Passlick-Deetjen J, et al. Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis. Pediatr Nephrol. 2008;23(9):1537–43.PubMedGoogle Scholar
  26. 26.
    Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B. Randomized double blinded trial of antibiotic exit site cream for the prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16:539–45.PubMedGoogle Scholar
  27. 27.
    Bernardini J, Price V, Figueiredo A. Peritoneal dialysis patient training, 2006. Perit Dial Int. 2006;26(6):625–32.PubMedGoogle Scholar
  28. 28.
    Blake PG, Korbert SM, Blake R, Bargman JM, Burkasts M, Delano BG, Dasgupta MK, Fine A, Finkelstein F, Mc Cusker FX, Mc Murray SD, Zabetakis PM, Zimmerman SW, Heidenheim P. A multicenter study of non compliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. Am J Kidney Dis. 2000;35:506–14.PubMedGoogle Scholar
  29. 29.
    Bloxum A, Powell N. The treatment of acute temporary dysfunction of the kidneys by peritoneal irrigation. Pediatrics. 1948;1:52–7.Google Scholar
  30. 30.
    Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, Zambrano P, Ahlenstiel T, Bakkaloglu SA, Spizzirri AP, Lopez L, Ozaltin F, Printza N, Hari P, Klaus G, Bak M, Vogel A, Ariceta G, Yap HK, Warady BA, Schaefer F, International Pediatric PD Network (IPPN). The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010;78:1295–304.PubMedGoogle Scholar
  31. 31.
    Borzych D, Ley S, Schaefer F, Billing H, Ley-Zaporozhan J, Schenk J, Schmitt CP. Dialysate leakage into pericardium in an infant on long-term peritoneal dialysis. Pediatr Nephrol. 2008;23(2):335–8.PubMedGoogle Scholar
  32. 32.
    Bouts AH, Davin JC, Groothoff JW, et al. Standard peritoneal permeability analysis in children. J Am Soc Nephrol. 2000;11:943–50.PubMedGoogle Scholar
  33. 33.
    Brandes JC, Packard WJ, Watters SK, Fritsche C. Optimization of dialysate flow and mass transfer during automated peritoneal dialysis. Am J Kidney Dis. 1998;25:603–10.Google Scholar
  34. 34.
    Brandt ML, Brewer ED. Peritoneal dialysis access in children. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. Dordrecht: Kluwer Academic; 2004. p. 83–9.Google Scholar
  35. 35.
    Braun N, Alscher MD, Fritz P, Latus J, Edenhofer I, Reimold F, Alper SL, Kimmel M, Biegger D, Lindenmeyer M, Cohen CD, Wüthrich RP, Segerer S. The spectrum of podoplanin expression in encapsulating peritoneal sclerosis. PLoS One. 2012;7(12):e53382.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int. 2001;21:275–81.PubMedGoogle Scholar
  37. 37.
    Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG. Outcome data on pediatric dialysis from the end-stage renal disease clinical indicators project. Am J Kidney Dis. 2000;36:310–7.PubMedGoogle Scholar
  38. 38.
    Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG. Prevalence of protein malnutrition in children maintained on peritoneal dialysis. Pediatr Nephrol. 2002;17:527–30.PubMedGoogle Scholar
  39. 39.
    Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol. 2006;17:2591–8.PubMedGoogle Scholar
  40. 40.
    Canepa A, Carrea A, Menoni S, Verrina E, Trivelli A, Gusmano R, Perfumo F. Acute effects of simultaneous intraperitoneal infusion of glucose and amino acids. Kidney Int. 2001;59:1967–73.PubMedGoogle Scholar
  41. 41.
    Canepa A, Perfumo F, Carrea A, Giallongo F, Verrina E, Cantalupi A, Gusmano R. Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol. 1991;5:215–9.PubMedGoogle Scholar
  42. 42.
    Canepa A, Verrina E, Perfumo F, Carrea A, Menoni S, Delucchi P, Gusmano R. Value of intraperitoneal amino acids in children treated with chronic peritoneal dialysis. Perit Dial Int. 1999;19 Suppl 2:S435–40.PubMedGoogle Scholar
  43. 43.
    Canepa A, Verrina E, Perfumo F. Use of new peritoneal dialysis solutions in children. Kidney Int. 2008;108:S137–44.Google Scholar
  44. 44.
    Cano F, Azocar M, Cavada G, Delucchi A, Marin V, Rodriguez E. Kt/V and nPNA in pediatric peritoneal dialysis: a clinical or a mathematical association? Pediatr Nephrol. 2006;21:114–8.PubMedGoogle Scholar
  45. 45.
    Cano F, Rojo A, Azocar M, Ibacache MJ, Delucchi A, Ugarte F, Irarrazabal C, Delgado I. The mini-PET in pediatric peritoneal dialysis: a useful tool to predict volume overload? Pediatr Nephrol. 2013;28(7):1121–6.PubMedGoogle Scholar
  46. 46.
    Cano F, Sanchez L, Rebori A, Quiroz L, Delucchi A, Delgado I, Aguilar MA, Azócar M, Castro F, Ibacache MJ, Cuevas M, Esquivel M. The short peritoneal equilibration test in pediatric peritoneal dialysis. Pediatr Nephrol. 2010;25(10):2159–64.PubMedGoogle Scholar
  47. 47.
    Canpolat N, Caliskan S, Sever L, Tasdemir M, Ekmekci OB, Pehlivan G, Shroff R. Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis. Pediatr Nephrol. 2013;28(11):2149–56.PubMedGoogle Scholar
  48. 48.
    Carey WA, Talley LI, Sehring SA, Jaskula JM, Mathias RS. Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies special analysis. Pediatrics. 2007;119:468–73.Google Scholar
  49. 49.
    Chada V, Blowey DL, Warady BA. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int. 2001;21 Suppl 3:S179–84.Google Scholar
  50. 50.
    Chada V, Jones LL, Ramirez ZD, Warady BA. Chest wall peritoneal dialysis catheter placement in infants with a colostomy. Adv Perit Dial. 2000;16:318–20.Google Scholar
  51. 51.
    Chada V, Schaefer F, Warady BA. Dialysis-associated peritonitis in children. Pediatr Nephrol. 2010;25:425–40.Google Scholar
  52. 52.
    Chadha V, Warady BA. Nutritional management of the child with kidney disease. In: Kopple JD, Massry SG, editors. Nutritional management of renal disease. Waltham: Elsevier; 2013. p. 581–603.Google Scholar
  53. 53.
    Chagnac A, Herskovitz P, Ori Y, Weinstein T, Hirsh J, Katz M, Gafter U. Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients. J Am Soc Nephrol. 2002;13(10):2554–9.PubMedGoogle Scholar
  54. 54.
    Chavers BM, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002;62:648–53.PubMedGoogle Scholar
  55. 55.
    Chen G, Wang P, Liu H, Zhou L, Cheng M, Liu Y, Zhang H, Li J, Sun L, Peng Y, Liu F. Greater omentum folding in the open surgical placement of peritoneal dialysis catheters: a randomized controlled study and systemic review. Nephrol Dial Transplant. 2014;29(3):687–97.PubMedGoogle Scholar
  56. 56.
    Chen HH, Shetty A, Afthentopoulos IF, Oreopoulos DG. Discrepancy between weekly Kt/V and weekly creatinine clearance in patients on CAPD. Adv Perit Dial. 1995;11:83–7.PubMedGoogle Scholar
  57. 57.
    Chen YT, Chang YT, Pan SY, Chou YH, Chang FC, Yeh PY, Liu YH, Chiang WC, Chen YM, Wu KD, Tsai TJ, Duffield JS, Lin SL. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol. 2014;25(12):2847–58.PubMedGoogle Scholar
  58. 58.
    Chesnaye N, Bonthuis M, Schaefer F, Groothoff JW, Verrina E, Heaf JG, Jankauskiene A, Lukosiene V, Molchanova EA, Mota C, Peco-Antić A, Ratsch IM, Bjerre A, Roussinov DL, Sukalo A, Topaloglu R, Van Hoeck K, Zagozdzon I, Jager KJ, Van Stralen KJ, ESPN/ERA–EDTA Registry. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry. Pediatr Nephrol. 2014;29(12):2403–10.PubMedGoogle Scholar
  59. 59.
    Chiu M-C, Fai-Ngor Ng C, Lee L-P, Lai WM, Lau SC. Automated peritoneal dialysis in children and adolescents-benefits; a survey of patients and parents on health-related quality of life. Perit Dial Int. 2007;27 Suppl 29:S138–42.PubMedGoogle Scholar
  60. 60.
    Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2014;3:CD007554.PubMedGoogle Scholar
  61. 61.
    Chua AN, Warady BA. Adherence of pediatric patients to automated peritoneal dialysis. Pediatr Nephrol. 2011;26(5):789–93.PubMedGoogle Scholar
  62. 62.
    Chung SH, Heimburger O, Lindholm B. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern. Semin Dial. 2008;21:7–10.PubMedGoogle Scholar
  63. 63.
    Churchill DN, Taylor DW, Keshaviah PK, Thorpe KE, Beecroft ML. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7:198–207.Google Scholar
  64. 64.
    Churchill DN. Impact of peritoneal dialysis dose guidelines on clinical outcome. Perit Dial Int. 2005;25 Suppl 3:S95–8.PubMedGoogle Scholar
  65. 65.
    Coleman JE, Watson AR. Growth post transplantation in children previously treated with chronic dialysis and gastrostomy feeding. Adv Perit Dial. 1998;14:269–73.PubMedGoogle Scholar
  66. 66.
    Coleman JE, Watson AR. Micronutrient supplementation in children on continuous cycling peritoneal dialysis (CCPD). Adv Perit Dial. 1992;8:396–401.PubMedGoogle Scholar
  67. 67.
    Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L. US renal data system 2012 annual data report. Am J Kidney Dis. 2013;61 Suppl 1:e1–480.Google Scholar
  68. 68.
    Cribbs RK, Greenbaum LA, Heiss KF. Risk factors for early peritoneal catheter failure in children. J Pediatr Surg. 2010;45:585–9.PubMedGoogle Scholar
  69. 69.
    Dart A, Feber J, Wong H, et al. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis. Pediatr Nephrol. 2005;20:683–5.PubMedGoogle Scholar
  70. 70.
    Daschner M, Gfrorer S, Zachariou Z, Mehls O, Schaefer F. Laparoscopic Tenckhoff catheter implantation in children. Perit Dial Int. 2002;22:22–6.PubMedGoogle Scholar
  71. 71.
    Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, Wieslander A, Chan C, Rippe B. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant. 2009;24(5):1609–17.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, Macnamara E, Ekstrand A, Tranaeus A, Filho JC, EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int. 2005;67:1609–15.PubMedGoogle Scholar
  73. 73.
    Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12(5):1046–51.PubMedGoogle Scholar
  74. 74.
    Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimbürger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14:2338–44.PubMedGoogle Scholar
  75. 75.
    De Boer AW, Schröder CH, Van Vliet R, Willems JL, Monnens LAH. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism. Pediatr Nephrol. 2000;15:21–4.PubMedGoogle Scholar
  76. 76.
    Dejardin A, Robert A, Goffin E. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications. Nephrol Dial Transplant. 2007;22(5):1437–44.PubMedGoogle Scholar
  77. 77.
    Dello Strologo L, Principato F, Sinibaldi D. Feeding dysfunction in infants with severe chronic renal failure after long-term nasogastric feeding. Pediatr Nephrol. 1997;11:84–6.PubMedGoogle Scholar
  78. 78.
    Devuyst O, Rippe B. Water transport across the peritoneal membrane. Kidney Int. 2014;85(4):750–8.PubMedGoogle Scholar
  79. 79.
    Distler L, Georgieva A, Kenkel I, Huppert J, Pischetsrieder M. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids. Chem Res Toxicol. 2014;27(8):1421–30.PubMedGoogle Scholar
  80. 80.
    Do JY, Kim YL, Park JW, Chang KA, Lee SH, Ryu DH, Kim CD, Park SH, Yoon KW. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis. Perit Dial Int. 2008;28 Suppl 3:S101–6.PubMedGoogle Scholar
  81. 81.
    Dolan NM, Borzych-Duzalka D, Suarez A, Principi I, Hernandez O, Al-Akash S, Alconchar L, Breen C, Fischbach M, Flynn J, Pape L, Piantanida JJ, Printza N, Wong W, Zaritsky J, Schaefer F, Warady BA, White CT. Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network. Pediatr Nephrol. 2013;28(2):315–9.PubMedGoogle Scholar
  82. 82.
    Donmez O, Durmaz O, Ediz B, Cigerdelen N, Kocak S. Catheter-related complications in children on chronic peritoneal dialysis. Adv Perit Dial. 2005;21:200–3.PubMedGoogle Scholar
  83. 83.
    Edefonti A, Boccola S, Picca M, Paglialonga F, Ardissino G, Marra G, Ghio L, Parisotto MT. Treatment data during pediatric home peritoneal dialysis. Pediatr Nephrol. 2003;18:560–4.PubMedGoogle Scholar
  84. 84.
    Edefonti A, Consalvo G, Picca M, Giani M, Damiani B, Ghio L, Galato R. Dialysis delivery in children in nightly intermittent and tidal peritoneal dialysis. Pediatr Nephrol. 1995;9:329–32.PubMedGoogle Scholar
  85. 85.
    Edefonti A, Paglialonga F, Picca M, Perfumo F, Verrina E, Lavoratti G, Rinaldi S, Rizzoni G, Zacchello G, Ciofani A, Sorino P, Loi S, Grassi MR. A prospective multicentre study of nutritional status in children on chronic peritoneal dialysis. Nephrol Dial Transplant. 2006;21:1946–51.PubMedGoogle Scholar
  86. 86.
    Edefonti A, Picca M, Damiani B, Loi S, Consalvo G, Giani M, Ghio L, Origgi G, Ferrario M. Models to assess nitrogen losses in pediatric patients on chronic peritoneal dialysis. Pediatr Nephrol. 2000;15:25–30.PubMedGoogle Scholar
  87. 87.
    Edefonti A, Picca M, Damiani B, Loi S, Ghio L, Giani M, Consalvo G, Grassi MR. Dietary prescription based on estimated nitrogen balance during peritoneal dialysis. Pediatr Nephrol. 1999;13:253–8.PubMedGoogle Scholar
  88. 88.
    Ellis EN, Blaszak C, Wright S, Van Lierop A. Effectiveness of home visits to pediatric peritoneal dialysis patients. Perit Dial Int. 2012;32(4):419–23.PubMedCentralPubMedGoogle Scholar
  89. 89.
    Erixon M, Wieslander A, Lindén T, Carlsson O, Forsbäck G, Svensson E, Jönsson JA, Kjellstrand P. How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int. 2006;26(4):490–7.PubMedGoogle Scholar
  90. 90.
    Feber J, Scharer K, Schaefer F, Mikova M, Janda J. Residual renal function in children on hemodialysis and peritoneal dialysis therapy. Pediatr Nephrol. 1994;8:579–83.PubMedGoogle Scholar
  91. 91.
    Filler G, Felder S. Trace elements in dialysis. Pediatr Nephrol. 2014;29(8):1329–35.PubMedGoogle Scholar
  92. 92.
    Fine RN, Ho M. The role of APD in the management of pediatric patients: a report of the North American pediatric renal transplant cooperative study. Semin Dial. 2002;15(6):427–9.PubMedGoogle Scholar
  93. 93.
    Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S. Superiority of icodextrin compared with 4.25 % dextrose for peritoneal ultrafiltration. J Am Soc Nephrol. 2005;16:546–54.PubMedGoogle Scholar
  94. 94.
    Fischbach M, Desprez P, Donnars F, Hamel G, Geisert J. Optimization of CCPD prescription in children using peritoneal equilibration test. Adv Perit Dial. 1994;10:307–9.PubMedGoogle Scholar
  95. 95.
    Fischbach M, Haraldsson B. Dynamic changes of total pore area available for peritoneal exchange in children. J Am Soc Nephrol. 2001;12:1524–9.PubMedGoogle Scholar
  96. 96.
    Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int. 2011;31:450–8.PubMedGoogle Scholar
  97. 97.
    Fischbach M, Stefanidis CJ, Watson AR. Guidelines by an ad hoc European committee on adequacy of the pediatric peritoneal dialysis prescription. Nephrol Dial Transplant. 2002;17:380–5.PubMedGoogle Scholar
  98. 98.
    Fischbach M, Terzic J, Chauvé S, Laugel V, Muller A, Haraldsson B. Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children. Nephrol Dial Transplant. 2004;19:925–32.PubMedGoogle Scholar
  99. 99.
    Fischbach M, Terzic J, Lahlou A, Berger MC, Eyer D, Desprez P, Geisert J. Nutritional effects of Kt/V in children on peritoneal dialysis: are there benefits from larger dialysis doses? Adv Perit Dial. 1995;11:306–8.PubMedGoogle Scholar
  100. 100.
    Fischbach M, Terzic J, Laugel V, Escande B, Dangelser C, Helmstetter A. Measurement of hydrostatic intraperitoneal pressure: a useful tool for the improvement of dialysis dose prescription. Pediatr Nephrol. 2003;18:976–80.PubMedGoogle Scholar
  101. 101.
    Fischbach M, Terzic J, Menouer S, Haraldsson B. Optimal volume prescription for children on peritoneal dialysis. Perit Dial Int. 2000;20:603–6.PubMedGoogle Scholar
  102. 102.
    Fischbach M, Terzic J, Menouer S, Soulami K, Dangelser C, Helmstetter A, Gehant F. Effects of automated peritoneal dialysis on residual daily urinary volume in children. Adv Perit Dial. 2001;17:269–73.PubMedGoogle Scholar
  103. 103.
    Fischbach M, Terzic J, Provot E, Weiss L, Bergere V, Menouer S, Soulami K. Intraperitoneal pressure in children: fill-volume related and impacted by body mass index. Perit Dial Int. 2003;23:391–4.PubMedGoogle Scholar
  104. 104.
    Fischbach M, Zaloszyc A, Schaefer B, Schmitt CP. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol. 2014;29(8):1321–7.PubMedGoogle Scholar
  105. 105.
    Flessner M, Henegar J, Bigler S, Genous L. Is the peritoneum a significant barrier in peritoneal dialysis? Perit Dial Int. 2003;23:542–9.PubMedGoogle Scholar
  106. 106.
    Flessner MF. Transport kinetics during peritoneal dialysis. In: Leypoldt JK, editors. The artificial kidney: physiological modelling and tissue engineering. Austin, Texas: R.G. Landes Company; 1999; p. 59–89.Google Scholar
  107. 107.
    Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–9.PubMedGoogle Scholar
  108. 108.
    Foster JB, Leonard MB. Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr. 2004;80:801–14.PubMedGoogle Scholar
  109. 109.
    Freida P, Issad B. Continuous cyclic peritoneal dialysis prescription and power. In: Ronco C, Amici G, Feriani M, Virga G, editors. Automated peritoneal dialysis. Basel: Karger; 1999. p. 99–108.Google Scholar
  110. 110.
    Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1982;34:2540–5.Google Scholar
  111. 111.
    Frischmann M, Spitzer J, Fünfrocken M, Mittelmaier S, Deckert M, Fichert T, Pischetsrieder M. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids. Biomed Chromatogr. 2009;23:843–51.PubMedGoogle Scholar
  112. 112.
    Furth SL, Gerson AC, Neu AM, Fivush BA. The impact of dialysis and transplantation on children. Adv Ren Replace Ther. 2001;8:206–13.PubMedGoogle Scholar
  113. 113.
    Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure. JAMA. 2001;285(8):1027–33.PubMedGoogle Scholar
  114. 114.
    Furth SL, Stablein D, Fine RN, Powe NR, Fivush BA. Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2002;109:909–13.PubMedGoogle Scholar
  115. 115.
    Gehan EA, George SL. Estimation of human body surface area from height and weight. Cancer Chemoter Rep. 1970;54:225–35.Google Scholar
  116. 116.
    Goldstein SL, Gerson AC, Furth S. Health-related quality of life for children with chronic kidney disease. Adv Chronic Kidney Dis. 2007;14:364–9.PubMedGoogle Scholar
  117. 117.
    Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol. 2006;21:846–50.PubMedGoogle Scholar
  118. 118.
    Goldstein SL, Graham N, Warady BA, Seikaly M, McDonald R, Burwinkle TM, Limbers CA, Varni JW. Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). Am J Kidney Dis. 2008;51:285–97.PubMedGoogle Scholar
  119. 119.
    Goldstein SL, Rosburg NM, Warady BA, Seikaly M, McDonald R, Limbers C, Varni JW. Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis. Pediatr Nephrol. 2009;24(8):1553–60.PubMedGoogle Scholar
  120. 120.
    Gotloib L, Shostak A, Bar-Sella P, Eiali V. Fenestrated capillaries in human parietal and rabbit diaphragmatic peritoneum. Nephron. 1985;41:200–2.PubMedGoogle Scholar
  121. 121.
    Greenbaum LA, Schaefer F. The decision to initiate dialysis in a pediatric patient. In: Warady BA, Schaefer F, Alexander SR, editors. Pediatric dialysis. New York: Springer; 2012. p. 85–100.Google Scholar
  122. 122.
    Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R, DIUREST Study Group. Low-GDP fluid (Gambrosol trio(R)) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant. 2010;25:2288–96.PubMedGoogle Scholar
  123. 123.
    Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F. Improved acidosis correction and recovery of mesothelial cells mass with neutral–pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol. 2003;14:2632–8.PubMedGoogle Scholar
  124. 124.
    Haraldsson B. Assessing the individual peritoneal dialysis capacities of individual patients. A clinical tool based on the three pore model. Kidney Int. 1995;47:1187–98.PubMedGoogle Scholar
  125. 125.
    Harris KP, Keogh AM, Alderson L. Peritoneal dialysis fill volume: can the patient tell the difference? Perit Dial Int. 2001;21 Suppl 3:S144–7.PubMedGoogle Scholar
  126. 126.
    Harvey EA. Non-infectious complications of peritoneal dialysis and hemodialysis. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. Dordrecht: Kluwer Academic; 2004. p. 415–41.Google Scholar
  127. 127.
    Hattori S, Yosioka K, Honda M, Ito H. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol. 2002;17:456–61.PubMedGoogle Scholar
  128. 128.
    Ho-dac-Pannekeet MM, Atasever B, Strujik DG, Krediet RT. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int. 1997;17:144–50.PubMedGoogle Scholar
  129. 129.
    Hölttä TM, Rönnholm KA, Jalanko H, Ala-Houhala M, Antikainen M, Holmberg C. Peritoneal dialysis in children under 5 years of age. Perit Dial Int. 1997;17:573–80.PubMedGoogle Scholar
  130. 130.
    Hölttä T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol. 2001;16:324–31.PubMedGoogle Scholar
  131. 131.
    Hölttä T, Rönnholm K, Holmerg C. Adequacy of dialysis with tidal and continuous cycling peritoneal dialysis in children. Nephrol Dial Transplant. 2000;15:1438–42.PubMedGoogle Scholar
  132. 132.
    Holmes CJ, Shockley TR. Strategies to reduce glucose exposure in peritoneal dialysis. Perit Dial Int. 2000;20:S37–41.PubMedGoogle Scholar
  133. 133.
    Honda M, Iitaka K, Kawaguchi H, Hoshii S, Akashi S, Kohsaka T, Tuzuki K, Yamaoka K, Yoshikawa N, Karashima S, Itoh Y, Hatae K. The Japanese national registry data on pediatric CAPD patients: a ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit Dial Int. 1996;16:269–75.PubMedGoogle Scholar
  134. 134.
    Honda M, Warady B. Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2010;25:75–81.PubMedCentralPubMedGoogle Scholar
  135. 135.
    Honda M. The 1997 report of the Japanese National Registry data on pediatric peritoneal dialysis patients. Perit Dial Int. 1999;19(Suppl 2):S473–8.Google Scholar
  136. 136.
    Hoshii S, Wada N, Honda M, Japanese Study Group of Pediatric Peritoneal Dialysis. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol. 2006;21(6):828–34.PubMedGoogle Scholar
  137. 137.
    Hou CH, Tsai TJ, Hsu KL. Peritoneopericardial communication after pericardiocentesis in a patient on continuous ambulatory peritoneal dialysis with dialysis pericarditis. Nephron. 1994;68:125–7.PubMedGoogle Scholar
  138. 138.
    Il-Soo H, Schaefer F. Conservation of residual renal function in children reaching end-stage renal disease. In: Warady BA, Schaefer F, Alexander SR, editors. Pediatric dialysis. New York: Springer; 2012. p. 139–50.Google Scholar
  139. 139.
    Italian Registry of Pediatric Chronic Dialysis. Peritonitis Report 2001–2003. http://www.sinepe.eu (2003).
  140. 140.
    Jansen MAM, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int. 2005;68:1199–205.PubMedGoogle Scholar
  141. 141.
    Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi M, Tan SH, Voss D, balANZ Trial Investigators. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol. 2012;23(6):1097–107.PubMedCentralPubMedGoogle Scholar
  142. 142.
    Karahan OI, Taskapan H, Yikilmaz A, Oymak O, Utas C. Ultrasound evaluation of peritoneal catheter tunnel in catheter related infections in CAPD. Int Urol Nephrol. 2005;37(2):363–6.PubMedGoogle Scholar
  143. 143.
    Kawaguchi AL, Dunn JC, Fonkalsrud EW. Management of peritoneal dialysis-induced hydrothorax in children. Am Surg. 1996;62:820–4.PubMedGoogle Scholar
  144. 144.
    Kazancioglu R. Peritoneal defense mechanisms–the effects of new peritoneal dialysis solutions. Perit Dial Int. 2009;29 Suppl 2:S198–201.PubMedGoogle Scholar
  145. 145.
    Kierdorf HP, Leue C, Arns S. Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int Suppl. 1999;72:S32–6.PubMedGoogle Scholar
  146. 146.
    Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, Oh KH, Kim HJ, Ahn C, Korean Balnet Study Group. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study). Perit Dial Int. 2008;28 Suppl 3:S117–22.PubMedGoogle Scholar
  147. 147.
    Kinashi H, Ito Y, Mizuno M, Suzuki Y, Terabayashi T, Nagura F, Hattori R, Matsukawa Y, Mizuno T, Noda Y, Nishimura H, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol. 2013;24(10):1627–42.PubMedCentralPubMedGoogle Scholar
  148. 148.
    Kohaut EC, Waldo FB, Brienfeld M. The effects of changes in dialysate volume on glucose and urea equilibration. Perit Dial Int. 1994;14:236–9.PubMedGoogle Scholar
  149. 149.
    Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, Gerlag PG, Hoorntje SJ, Wolters J, van der Sande FM, Leunissen KM. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int. 2003;63:1556–63.PubMedGoogle Scholar
  150. 150.
    Kopanati S, Baum M, Quan A. Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis. Pediatr Nephrol. 2006;21(7):1013–9.PubMedGoogle Scholar
  151. 151.
    Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, Lewis MA, Boehm M, Simonetti GD, Novljan G, Groothoff JW. Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int. 2011;80:1092–8.PubMedGoogle Scholar
  152. 152.
    Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int. 2000;20 Suppl 4:S22–42.PubMedGoogle Scholar
  153. 153.
    Krediet RT. The physiology of peritoneal transport and ultrafiltration. In: Gokal R, Khanna R, Krediet RT, Nolph K, editors. Textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers Group; 2000. p. 135–73.Google Scholar
  154. 154.
    Kriley M, Warady BA. Vitamin status of pediatric patients receiving long-term peritoneal dialysis. Am J Clin Nutr. 1991;531:1476–9.Google Scholar
  155. 155.
    Krishnan RG, Ognjanovic MV, Crosier J, Coulthard MG. Acute hydrothorax complicating peritoneal dialysis. Perit Dial Int. 2007;27:296–9.PubMedGoogle Scholar
  156. 156.
    La Milia S, Pozzoni P, Virga G, Crepaldi M, Del Vecchio L, Andrulli S, Locatelli F. Peritoneal transport assessment by peritoneal equilibration test with 3.86 % glucose: a long-term prospective evaluation. Kidney Int. 2006;69:927–33.PubMedGoogle Scholar
  157. 157.
    Laakkonen H, Holtta T, Lonnqvist T, Holmberg C, Rönnholm K. Peritoneal dialysis in children under two years of age. Nephrol Dial Transplant. 2008;23:1747–53.PubMedGoogle Scholar
  158. 158.
    Laakkonen H, Happonen J-M, Marttinen E, Paganus A, Holltta T, Holmberg C, Ronholm K. Normal growth and intravascular volume status with good metabolic control during peritoneal dialysis in infancy. Pediatr Nephrol. 2010;25:1529–38.PubMedCentralPubMedGoogle Scholar
  159. 159.
    Ladd AP, Breckler FD, Novotny NM. Impact of primary omentectomy on longevity of peritoneal dialysis catheters in children. Am J Surg. 2011;201(3):401–4.PubMedGoogle Scholar
  160. 160.
    Lapeyraque AL, Haddad E, André JL, Brémond-Gignac D, Taylor CM, Rianthavorn P, Salusky IB, Loirat C. Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis. Am J Kidney Dis. 2003;42(5):E3–9.PubMedGoogle Scholar
  161. 161.
    Lederman S. When should gastrostomy tubes be removed following successful renal transplantation? Pediatr Transplant. 2005;9:553–4.Google Scholar
  162. 162.
    Lederman SE, Shaw V, Trompeter RS. Long-term enteral nutrition in infants and young children with chronic renal failure. Pediatr Nephrol. 1999;13:870–5.Google Scholar
  163. 163.
    Lederman SE, Spitz L, Moloney J, Rees L, Trompeter RS. Gastrostomy feeding in infants and children on peritoneal dialysis. Pediatr Nephrol. 2002;17:246–50.Google Scholar
  164. 164.
    Leonard MB, Donaldson LA, Ho M, Geary DF. A prospective cohort study of incident maintenance dialysis in children: an NAPRTCS study. Kidney Int. 2003;63:744–55.PubMedGoogle Scholar
  165. 165.
    Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003;139:105–12.PubMedGoogle Scholar
  166. 166.
    Litwin M, Grenda R, Sladowska J, Antoniewicz J. Add-on therapy with angiotensin II receptor I blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol. 2006;21(11):1716–22.PubMedGoogle Scholar
  167. 167.
    Lo W-K, Ho Y-W, Li C-C, Wong K-S, Chan T-M, Yu W-Y. Effect of Kt/V survival and clinical outcome in CAPD patients in a prospective randomised trial. Kidney Int. 2003;64:649–56.PubMedGoogle Scholar
  168. 168.
    Mactier RA, Khanna R, Moore H, Russ J, Nolph KD, Groshong T. Kinetics of peritoneal dialysis in children: role of lymphatics. Kidney Int. 1988;34:82–8.PubMedGoogle Scholar
  169. 169.
    Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, Wrege U, Gröntoft KC, Larsson R, Berglund J, Tranaeus AP, Faict D. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int. 1998;53:1061–7.PubMedGoogle Scholar
  170. 170.
    Madden SI, Lederman SE, Guerrero-Blanco M, Bruce M, Trompeter RS. Cognitive and psychosocial outcome of infants dialysed in infancy. Child Care Health Dev. 2003;29:55–61.PubMedGoogle Scholar
  171. 171.
    Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini E, Movilli E, Pola A, d’Avolio G, Gelatti U. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant. 1995;10:2295–305.PubMedGoogle Scholar
  172. 172.
    Mak RH, Cheung W, Cone RD, Marks DL. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 2006;69:794–7.PubMedGoogle Scholar
  173. 173.
    Mak RH, Cheung W, Cone RD, Marks DL. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol. 2005;20:427–31.PubMedGoogle Scholar
  174. 174.
    Malhotra C, Murata GH, Tzamaloukas AH. Creatinine clearance and urea clearance in PD. What to do in case of discrepancy. Perit Dial Int. 1997;17:532–5.PubMedGoogle Scholar
  175. 175.
    Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier MA, Mendoza O, Goud N, Costigan A, Denjoy N, Verger C, Owen Jr WF. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet. 2005;365:588–94.PubMedGoogle Scholar
  176. 176.
    Mastrangelo A, Paglialonga F, Edefonti A. Assessment of nutritional status in children with chronic kidney disease and on dialysis. Pediatr Nephrol. 2014;29:1349–58.PubMedGoogle Scholar
  177. 177.
    Mattioli G, Castagnetti M, Verrina E, Trivelli A, Torre M, Jasonni V, Perfumo F. Laparoscopic-assisted peritoneal dialysis catheter implantation in pediatric patients. Urology. 2007;69:1185–9.PubMedGoogle Scholar
  178. 178.
    McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2654–62.PubMedGoogle Scholar
  179. 179.
    McKenna AM, Keating LE, Vigneux A, Stevens S, Williams A, Geary DF. Quality of life in children with chronic kidney disease – patient and caregiver assessments. Nephrol Dial Transplant. 2006;21:1899–905.PubMedGoogle Scholar
  180. 180.
    Mellits ED, Cheek DB. The assessment of body water and fatness from infancy to adulthood. Monogr Soc Res Child Dev. 1970;35:12–26.PubMedGoogle Scholar
  181. 181.
    Mendley SR, Majkowski NL. Urea and nitrogen excretion in pediatric peritoneal dialysis patients. Kidney Int. 2000;58:2564–70.PubMedGoogle Scholar
  182. 182.
    Mitsnefes M, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005;45:309–15.PubMedGoogle Scholar
  183. 183.
    Montini G, Amici G, Milan S, Mussap M, Naturale M, Ratsch I-M, Ammenti A, Sorino P, Verrina E, Andreetta B, Zacchello G. Middle molecule and small protein removal in children on peritoneal dialysis. Kidney Int. 2002;61:1153–9.PubMedGoogle Scholar
  184. 184.
    Morgenstern B. Peritoneal dialysis and prescription monitoring. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. Dordrecht: Kluwer Academic; 2004. p. 147–61.Google Scholar
  185. 185.
    Morgenstern BZ, Wühl E, Sreekumaran Nair K, Warady B, Schaefer F. Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis. J Am Soc Nephrol. 2006;17:285–93.PubMedGoogle Scholar
  186. 186.
    Morgenstern BZ. Equilibration testing: close, but not quite right. Pediatr Nephrol. 1993;7:1309–12.Google Scholar
  187. 187.
    Mortier S, Faict D, Gericke M, Lameire N, De VA. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane. Nephron Exp Nephrol. 2005;101(4):e139–45. Epub 2005 Aug 30.PubMedGoogle Scholar
  188. 188.
    Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int. 2004;66:1257–65.PubMedGoogle Scholar
  189. 189.
    Mujais S, Nolph K, Blake P, Burkart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S, Krediet R, Lindholm B, Oreopoulus D, Rippe B, Selgas R. Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int. 2000;20 Suppl 4:S5–21.PubMedGoogle Scholar
  190. 190.
    Nather S, Anger H, Koall W, Reis A, Mukhtar B, Grimm C, Drescher J, Osten B. Peritoneal leak and chronic pericardial effusion in a CAPD patient. Nephrol Dial Transplant. 1996;11:1155–8.PubMedGoogle Scholar
  191. 191.
    National Kidney Foundation. KDOQI clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis. 2006;48(Suppl1):S1–322.Google Scholar
  192. 192.
    National Kidney Foundation Kidney Disease Quality Outcome Initiative (KDOQI). Clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis. 2009;53 Suppl 2:S1–124.Google Scholar
  193. 193.
    National Kidney Foundation. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 1997;30 Suppl 2:S67–136.Google Scholar
  194. 194.
    National Kidney Foundation. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy, 2000. Am J Kidney Dis. 2001;37 Suppl 1:S65–136.Google Scholar
  195. 195.
    Neu AM, Ho PL, McDonald RA, Warady BA. Chronic dialysis in children and adolescents. The 2001 NAPRTCS annual report. Pediatr Nephrol. 2002;17:656–63.PubMedGoogle Scholar
  196. 196.
    Neu AM, Sander A, Borzych-Duzalka D, Watson AR, Vallés PG, Ha IS, Patel H, Askenazi D, Balasz-Chmielewska I, Lauronen J, Groothoff JW, Feber J, Schaefer F, Warady BA, IPPN investigators. Comorbidities in chronic pediatric peritoneal dialysis patients: a report of the International Pediatric Peritoneal Dialysis Network. Perit Dial Int. 2012;32(4):410–8.PubMedCentralPubMedGoogle Scholar
  197. 197.
    Neul SK, Minard CG, Currier H, Goldstein SL. Health related quality of life functioning over a 2-year period in children with end-stage renal disease. Pediatr Nephrol. 2013;28(2):285–93.PubMedGoogle Scholar
  198. 198.
    Nolph KD, Twardowski ZJ, Khanna R, Moore HL, Prowant BF. Predicted and measured daily creatinine production in CAPD: identifying non-compliance. Perit Dial Int. 1995;15:22–5.PubMedGoogle Scholar
  199. 199.
    Norman LJ, Coleman JE, Watson AR. Nutritional supplements and elevated serum vitamin A levels in children on chronic dialysis. J Hum Nutr Diet. 1996;9:257–62.Google Scholar
  200. 200.
    North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). 2008 Annual Report. http://www.naprtcs.org (2008).
  201. 201.
    North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). 2011 Annual Report. http://www.naprtcs.org (2011).
  202. 202.
    Olszowska A, Wanieski J, Werynski A, Anderstam B, Lindholm B, Wankowicz Z. Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acid-based solutions. Perit Dial Int. 2007;27:544–53.PubMedGoogle Scholar
  203. 203.
    Opatrnà S, Opatrny K, Racek J, Sefrna F. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance. Perit Dial Int. 2003;23:89–91.PubMedGoogle Scholar
  204. 204.
    Paglialonga F, Edefonti A. Nutrition assessment and management in children on peritoneal dialysis. Pediatr Nephrol. 2009;24:721–30.PubMedGoogle Scholar
  205. 205.
    Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomised controlled trial. J Am Soc Nephrol. 2002;13:1307–20.PubMedGoogle Scholar
  206. 206.
    Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D. NTproBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551–7.PubMedGoogle Scholar
  207. 207.
    Paniagua R, Ventura MJ, Rodriguez E, Sil J, Galindo T, Hurtado ME, Alcantara G, Chimalpopoco A, Gonzalez I, Sanjurjo A, Barron L, Amato D, Mujais S. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int. 2004;24:156–62.PubMedGoogle Scholar
  208. 208.
    Parekh RS. Cardiovascular complications in pediatric end-stage renal disease. Pediatr Nephrol. 2005;20:125–31.PubMedGoogle Scholar
  209. 209.
    Park KS, Hwang YJ, Cho MH, Ko CW, Ha IS, Kang HG, Cheong HI, Park YS, Lee YJ, Lee JH, Cho HY. Quality of life in children with end-stage renal disease based on a PedQL ESRD module. Pediatr Nephrol. 2012;27(12):2293–300.PubMedGoogle Scholar
  210. 210.
    Per H, Canpolat M, Gümüş H, Poyrazoğlu HG, Yıkılmaz A, Karaküçük S, Doğan H, Kumandaş S. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2013;35(6):561–8.PubMedGoogle Scholar
  211. 211.
    Phakdeekitcharoen B, Leelasa-nguan P. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis. 2004;44:738–46.PubMedGoogle Scholar
  212. 212.
    Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L, ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107–31.PubMedGoogle Scholar
  213. 213.
    Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int. 2003;23:456–9.PubMedGoogle Scholar
  214. 214.
    Popovich RP, Moncrief JW, Decherd JW, et al. The definition of a novel wearable/portable equilibrium peritoneal dialysis technique. Trans Am Soc Artif Intern Organs. 1976;5:64.Google Scholar
  215. 215.
    Posthuma N, ter Wee PM, Donker AJM, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. Perit Dial Int. 2000;20 Suppl 2:S106–13.PubMedGoogle Scholar
  216. 216.
    Pride ET, Gustafson J, Graham A, Spoinhour L, Mauck V, Brown P, Burkart JM. Comparison of a 2.5 % and a 4.25 % dextrose peritoneal equilibration test. Perit Dial Int. 2002;22:365–70.PubMedGoogle Scholar
  217. 217.
    Quan A, Baun M. Protein losses in children on continuous cycler peritoneal dialysis. Pediatr Nephrol. 1996;10:728–31.PubMedGoogle Scholar
  218. 218.
    Ramage IJ, Harvey E, Geary DF, Hébert D, Balfe JA, Balfe JW. Complications of gastrostomy feeding in children receiving peritoneal dialysis. Pediatr Nephrol. 1999;13:249–52.PubMedGoogle Scholar
  219. 219.
    Rees L, Azocar M, Borzych D, Watson AR, Büscher A, Edefonti A, Bilge I, Askenazi D, Leozappa G, Gonzales C, van Hoeck K, Secker D, Zurowska A, Rönnholm K, Bouts AH, Stewart H, Ariceta G, Ranchin B, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (IPPN) registry. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol. 2011;22(12):2303–12.PubMedCentralPubMedGoogle Scholar
  220. 220.
    Rees L, Brandt ML. Tube feeding in children with chronic kidney disease: technical and practical issues. Pediatr Nephrol. 2010;25:699–704.PubMedGoogle Scholar
  221. 221.
    Rees L, Shaw V. Nutrition in children with CRF and on dialysis. Pediatr Nephrol. 2007;22:1689–702.PubMedCentralPubMedGoogle Scholar
  222. 222.
    Rees L. Long-term peritoneal dialysis in infants. Perit Dial Int. 2007;27 Suppl 2:S180–4.PubMedGoogle Scholar
  223. 223.
    Reimann D, Dachs D, Meye C, Gross P. Amino acid-based peritoneal dialysis solution stimulates mesothelial nitric oxide production. Perit Dial Int. 2004;24(4):378–8464.PubMedGoogle Scholar
  224. 224.
    Riano-Galan I, Malaga S, Rajmil L, Ariceta G, Navarro M, Loris C, Vallo A. Quality of life of adolescents with end-stage renal disease and kidney transplant. Pediatr Nephrol. 2009;24(8):1561–8.PubMedGoogle Scholar
  225. 225.
    Rinaldi S, Sera F, Verrina E, Edefonti A, Gianoglio B, Perfumo F, Sorino P, Zacchello G, Cutaia I, Lavoratti G, Leozappa G, Pecoraro C, Rizzoni G, Italian Registry of Pediatric Chronic Peritoneal Dialysis. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian registry of pediatric chronic dialysis. Perit Dial Int. 2004;24:481–6.PubMedGoogle Scholar
  226. 226.
    Rippe B, Rosengren BI, Venturoli D. The peritoneal microcirculation in peritoneal dialysis. Microcirculation. 2001;8(5):303–20.PubMedGoogle Scholar
  227. 227.
    Rippe B. Is lymphatic absorption important for ultrafiltration? Perit Dial Int. 1995;15:203–4.PubMedGoogle Scholar
  228. 228.
    Roodhooft AM, Van Hoeck KJ, Van Acker KJ. Hypophosphatemia in infants on continuous ambulatory peritoneal dialysis. Clin Nephrol. 1990;34:131–5.PubMedGoogle Scholar
  229. 229.
    Rosengren BI, Rippe B. Blood flow limitation in vivo of small solute transfer during peritoneal dialysis in rats. J Am Soc Nephrol. 2013;14(6):1599–604.Google Scholar
  230. 230.
    Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis populations. J Am Soc Nephrol. 2006;17:271–8.PubMedGoogle Scholar
  231. 231.
    Rusthoven E, Krediet RT, Willems HL, Monnens LA, Schröder CH. Sodium sieving in children. Perit Dial Int. 2005;25 Suppl 3:S141–2.PubMedGoogle Scholar
  232. 232.
    Sakar S, Bernardini J, Fried L, Johnston JR, Piraino B. Tolerance of large exchange volumes by peritoneal dialysis patients. Am J Kidney Dis. 1999;33:1136–41.Google Scholar
  233. 233.
    Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel–Aguirre A, Soo A, Hemmelgarn BR, Pediatric Renal Outcomes Canada Group. Survival in pediatric dialysis and transplant patients. Clin J Am Soc Nephrol. 2011;6:1094–9.PubMedCentralPubMedGoogle Scholar
  234. 234.
    Sardegna KM, Beck AM, Strife CF. Evaluation of perioperative antibiotics at the time of dialysis catheter placement. Pediatr Nephrol. 1998;12:149–52.PubMedGoogle Scholar
  235. 235.
    Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol. 2008;23(5):695–703.PubMedGoogle Scholar
  236. 236.
    Schaefer B, Bartosova M, Goeppinger-Macher S, Holland-Cunz S, Querfeld U, Warady BA, Schaefer F, Schmitt CP. Update on the international peritoneal biopsy study in children. Perit Dial Int. 2014, in press.Google Scholar
  237. 237.
    Schaefer F, Klaus G, Mehls O, Mid-European Pediatric Peritoneal Dialysis Study Group. Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. J Am Soc Nephrol. 1999;10:1786–92.PubMedGoogle Scholar
  238. 238.
    Schaefer F. The PET-iatrics of peritoneal solute transport: is short also good for the young ones? Perit Dial Int. 2007;27:413–4.PubMedGoogle Scholar
  239. 239.
    Schaefer F, Langebeck D, Heckert KH, Scharer K, Mehls O. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial. 1992;8:410–5.PubMedGoogle Scholar
  240. 240.
    Schaefer F, Borzych-Duzalka D, Azocar M, Munarriz RL, Sever L, Aksu N, Barbosa LS, Galan YS, Xu H, Coccia PA, Szabo A, Wong W, Salim R, Vidal E, Pottoore S, Warady BA, IPPN investigators. Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int. 2012;32(4):399–409.PubMedCentralPubMedGoogle Scholar
  241. 241.
    Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Möller K, von Baum H, Warady BA. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int. 2007;72:1374–9.PubMedGoogle Scholar
  242. 242.
    Schaefer F, Haraldsson B, Haas S, Simkova E, Feber J, Mehls O. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int. 1998;54:1372–9.PubMedGoogle Scholar
  243. 243.
    Schaefer F, Klaus G, Mueller-Wiefel DE, Mehls O. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis peritonitis. J Am Soc Nephrol. 1999;10:136–45.PubMedGoogle Scholar
  244. 244.
    Schaefer F, Wolf S, Klaus G, Langenbeck D, Mehls O. Higher Kt/V urea associated with greater protein catabolic rate and dietary protein intake in children treated with CCPD compared to CAPD. Adv Perit Dial. 1994;10:310–4.PubMedGoogle Scholar
  245. 245.
    Schaefer F, Wühl E, Feneberg R, Mehls O, Scharer K. Assessment of body composition in children with chronic renal failure. Pediatr Nephrol. 2000;14:673–8.PubMedGoogle Scholar
  246. 246.
    Schalkwijk CG, ter Wee PM, Teerlink T. Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids. Perit Dial Int. 2000;20:796–8.PubMedGoogle Scholar
  247. 247.
    Scharer K, Fine RN. The history of dialysis therapy in children. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. Dordrecht: Kluwer Academic; 2004. p. 1–11.Google Scholar
  248. 248.
    Schmitt CP, Bakkaloglu SA, Klaus G, Schröder C, Fischbach M, European Pediatric Dialysis Working Group. Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group. Pediatr Nephrol. 2011;26(7):1137–47.PubMedGoogle Scholar
  249. 249.
    Schmitt CP, Borzych D, Nau B, Wühl E, Zurowska A, Schaefer F. Dialytic phosphate removal: a modifiable measure of dialysis efficacy in automated peritoneal dialysis. Perit Dial Int. 2009;29(4):465–71.PubMedGoogle Scholar
  250. 250.
    Schmitt CP, Dötschmann R, Daschner M, Zimmering M, Greiner C, Böswald M, Klaus G, Schaefer F. Residual peritoneal volume and body size in children on peritoneal dialysis. [Members of the Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS)]. Adv Perit Dial. 1999;15:287–90.PubMedGoogle Scholar
  251. 251.
    Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Böswald M, Klaus G, Passlick-Deetjen J, Schaefer F. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport in children. Kidney Int. 2002;61:1527–36.PubMedGoogle Scholar
  252. 252.
    Schmitt CP, Nau B, Gemulla G, Bonzel KE, Hölttä T, Testa S, Fischbach M, John U, Kemper MJ, Sander A, Arbeiter K, Schaefer F. Effect of the dialysis fluid buffer on peritoneal membrane function in children. Clin J Am Soc Nephrol. 2013;8(1):108–15.PubMedCentralPubMedGoogle Scholar
  253. 253.
    Schmitt CP, von Heyl D, Rieger S, Arbeiter K, Bonzel KE, Fischbach M, Misselwitz J, Pieper AK, Schaefer F, The Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant. 2007;22:2038–44.PubMedGoogle Scholar
  254. 254.
    Schmitt CP, Zaloszyc A, Schaefer B, Fischbach M. Peritoneal dialysis tailored to pediatric needs. Int J Nephrol. 2011;2011:940267. doi:10.4061/2011/940267. Epub 8 Jun 2011.PubMedCentralPubMedGoogle Scholar
  255. 255.
    Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol. 2007;22(11):1839–48.PubMedGoogle Scholar
  256. 256.
    Segar WE, Gibson RK, Rhamy R. Peritoneal dialysis in infants and children. Pediatrics. 1961;27:603–13.PubMedGoogle Scholar
  257. 257.
    Shea M, Hmiel SP, Beck AM. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children. Adv Perit Dial. 2001;17:249–52.PubMedGoogle Scholar
  258. 258.
    Shroff R, Ledermann S. Long-term outcome of chronic dialysis children. Pediatr Nephrol. 2009;24(3):463–74.PubMedCentralPubMedGoogle Scholar
  259. 259.
    Shroff R, Rees L, Trompeter R, Hutchinson C, Ledermann S. Long-term outcome of chronic dialysis in children. Pediatr Nephrol. 2006;21:257–64.PubMedGoogle Scholar
  260. 260.
    Shroff R, Stefanidis CJ, Askiti V, Edefonti A, Testa S, Ekim M, Kavaz A, Ariceta G, Bakkaloglu S, Fischbach M, Klaus G, Zurowska A, Holtta T, Jankauskiene A, Vondrak K, Vande Walle J, Schmitt CP, Watson AR, European Paediatric Dialysis Working Group. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant. 2013;28(7):1908–14.PubMedGoogle Scholar
  261. 261.
    Simonsen O, Sterner G, Carlson O, Wieslander A, Rippe B. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture. Perit Dial Int. 2006;26:353–9.PubMedGoogle Scholar
  262. 262.
    Simonsen O, Venturoli D, Wieslander A, Carlsson O, Rippe B. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations. Kidney Int. 2003;64(1):208–15.PubMedGoogle Scholar
  263. 263.
    Sitter T, Sauter M. Impact of glucose in peritoneal dialysis: saint or sinner. Perit Dial Int. 2005;25:415–25.PubMedGoogle Scholar
  264. 264.
    Stadermann MB, Rusthoven E, van de Kar NC, Hendriksen A, Monnens LA, Schröder CH. Local fibrinolytic therapy with urokinase for peritoneal dialysis catheter obstruction in children. Perit Dial Int. 2002;22:84–6.PubMedGoogle Scholar
  265. 265.
    Stringel G, McBride W, Weiss R. Laparoscopic placement of peritoneal dialysis catheters in children. J Pediatr Surg. 2008;43:857–60.PubMedGoogle Scholar
  266. 266.
    Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis. 2004;44:591–603.PubMedGoogle Scholar
  267. 267.
    Stuart S, Booth TC, Cash CJ, Hameeduddin A, Goode JA, Harvey C, Malhotra A. Complications of continuous ambulatory peritoneal dialysis. Radiographics. 2009;29(2):441–60.PubMedGoogle Scholar
  268. 268.
    Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004;43:1056–64.PubMedGoogle Scholar
  269. 269.
    Szeto CC, Chow KM. Pathogenesis and management of hydrothorax complicating peritoneal dialysis. Curr Opin Pulm Med. 2004;10:315–9.PubMedGoogle Scholar
  270. 270.
    Tam P, Sheldrake P, Ng A, Oreopoulos DG, Sloand JA. Peritoneal equilibration testing: correcting the correction factor. Perit Dial Int. 2009;29:352–5.PubMedGoogle Scholar
  271. 271.
    Tenckhoff H, Meston B, Shilipetar G. A simplified automatic peritoneal dialysis system. Trans Am Soc Artif Intern Organs. 1972;18:436–40.PubMedGoogle Scholar
  272. 272.
    Tenckhoff H, Schecter H. A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs. 1964;14:181–6.Google Scholar
  273. 273.
    Thongboonkerd V, Lumlertgul D, Supajatura V. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis. Artif Organs. 2001;25:99–108.PubMedGoogle Scholar
  274. 274.
    Topley N, Kaur D, Petersen MM, Jörres A, Passlick-Deetjen J, Coles GA, Williams JD. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int. 1996;49:1447–56.PubMedGoogle Scholar
  275. 275.
    Tranaeus A. A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution–clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int. 2000;20:516–23.PubMedGoogle Scholar
  276. 276.
    Tsai TC, Liu SI, Tsai JD, Chou LH. Psychosocial effects on caregivers for children on chronic peritoneal dialysis. Kidney Int. 2006;70(11):1983–7.PubMedGoogle Scholar
  277. 277.
    Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138–47.Google Scholar
  278. 278.
    US Renal Data System. The Concise 2009 Annual Data Report: National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda; 2009.Google Scholar
  279. 279.
    Valdebarrano F, Jofre R, Lopez-Gomez M. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001;38:443–64.Google Scholar
  280. 280.
    van Stralen KJ, Borzych-Dużalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, Inward C, Rönnholm K, Vondrak K, Warady BA, Zurowska AM, Schaefer F, Cochat P. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int. 2014;86(1):168–1674.PubMedGoogle Scholar
  281. 281.
    Velasco RF, Munoz JL, Saavedra VS, et al. Automated peritoneal dialysis as the modality of choice: a single-centre, 3-year experience with 458 children in Mexico. Pediatr Nephrol. 2008;23:465–71.Google Scholar
  282. 282.
    Verduijn M, Maréchal C, Coester AM, Sampimon DE, Boeschoten EW, Dekker FW, Goffin E, Krediet RT, Devuyst O. The -174G/C variant of IL6 as risk factor for mortality and technique failure in a large cohort of peritoneal dialysis patients. Nephrol Dial Transplant. 2012;27(9):3516–23.PubMedGoogle Scholar
  283. 283.
    Verrina E, Amici G, Perfumo F, Trivelli A, Canepa A, Gusmano R. The use of PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis. Perit Dial Int. 1998;18:322–8.PubMedGoogle Scholar
  284. 284.
    Verrina E, Bassi S, Perfumo F, Edefonti A, Zacchello G, Andreetta B, Pela I, Penza R, Piaggio G, Picca M. Analysis of complications in a chronic peritoneal dialysis pediatric patient population. The Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int. 1993;13 Suppl 2:S257–9.PubMedGoogle Scholar
  285. 285.
    Verrina E, Brendolan A, Gusmano R, Ronco C. Chronic replacement therapy in children: which index is best for adequacy? Kidney Int. 1998;54:1690–6.PubMedGoogle Scholar
  286. 286.
    Verrina E, Edefonti A, Gianoglio B, Rinaldi S, Sorino P, Zacchello G, Lavoratti G, Maringhini S, Pecoraro C, Calevo MG, Turrini Dertenois L, Perfumo F. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol. 2004;19:82–90.PubMedGoogle Scholar
  287. 287.
    Verrina E, Zacchello G, Perfumo F, Edefonti A, Sorino P, Bassi S, Andreetta B, Cattarelli D, Capasso G, Consalvo G. Clinical experience in the treatment of infants with chronic peritoneal dialysis. Adv Perit Dial. 1995;11:281–4.PubMedGoogle Scholar
  288. 288.
    Vidal E, Edefonti A, Puteo F, Chimenz R, Gianoglio B, Lavoratti G, Leozappa G, Maringhini S, Mencarelli F, Pecoraro C, Ratsch IM, Cannavò R, De Palo T, Testa S, Murer L, Verrina E. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients: the experience of the Italian Registry of Pediatric Chronic Dialysis. Nephrol Dial Transplant. 2013;28(6):1603–9.PubMedGoogle Scholar
  289. 289.
    Vidal E, Edefonti A, Murer L, Gianoglio B, Maringhini S, Pecoraro C, Sorino P, Leozappa G, Lavoratti G, Ratsch IM, Chimenz R, Verrina E, Italian Registry of Paediatric Chronic Dialysis. Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol Dial Transplant. 2012;27(1):388–95.PubMedGoogle Scholar
  290. 290.
    Vonesh EF. Membrane transport models and computerized kinetic modeling applied to automated peritoneal dialysis. In: Ronco C, Amici G, Feriani M, Virga G, editors. Automated peritoneal dialysis. Basel: Karger; 1999. p. 15–34.Google Scholar
  291. 291.
    Wang T, Heimburger O, Cheng HH, Vanieski J, Bergstrom J, Lindholm B. Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int. 1997;52:1068–76.PubMedGoogle Scholar
  292. 292.
    Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant. 1992;7(1):50–6.PubMedGoogle Scholar
  293. 293.
    Warady BA, Schaefer F, Alexander SR, Firanek C, Mujais S. Care of the pediatric patient on peritoneal dialysis. Clinical process for optimal outcomes. Deerfield, Illinois: Baxter Healthcare; 2004.Google Scholar
  294. 294.
    Warady BA, Jennings J. The short PET in pediatrics. Perit Dial Int. 2007;27:441–5.PubMedGoogle Scholar
  295. 295.
    Warady BA, Alexander SR, Firanek C, Holloway M, Honda M, Kandert M, Mujais S, Piraino B, Saluski I, Schaefer F, Tranaeus A, Verrina E. Peritoneal dialysis catheter and complications management for children: clinical process for optimal outcomes. Deerfield, Illinois: Baxter Healthcare Corporation; 2001.Google Scholar
  296. 296.
    Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Kohaut EC. The relationship between intraperitoneal volume and solute transport in pediatric patients. J Am Soc Nephrol. 1995;5:1935–9.PubMedGoogle Scholar
  297. 297.
    Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Watkins S, Salusky IB, Kohaut EC. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol. 1996;7:2385–91.PubMedGoogle Scholar
  298. 298.
    Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012;32 Suppl 2:S32–86.PubMedCentralPubMedGoogle Scholar
  299. 299.
    Warady BA, Ellis EN, Fivush BA, Lum GM, Alexander SR, Brewer ED, Ogrinc F, Watkins SL. Flush before fill in children receiving automated peritoneal dialysis. Perit Dial Int. 2003;23:493–8.PubMedGoogle Scholar
  300. 300.
    Warady BA, Feneberg R, Verrina E, Flynn JT, Muller-Wiefel DE, Besbas N, Zurowska A, Aksu N, Fischbach M, Sojo E, Donmez O, Sever L, Sirin A, Alexander SR, Schaefer F. Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol. 2007;18:2172–9.PubMedGoogle Scholar
  301. 301.
    Warady BA, Fivush BA, Andreoli SP, Kohaut E, Salusky I, Schlichting L, Pu K, Watkins S. Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis. Pediatr Nephrol. 1999;13:571–6.PubMedGoogle Scholar
  302. 302.
    Warady BA, Kriley M, Alon U, Hellerstein S. Vitamin status of infants receiving long-term peritoneal dialysis. Pediatr Nephrol. 1994;8:354–6.PubMedGoogle Scholar
  303. 303.
    Warady BA, Neu AM, Schaefer F. Optimal care for the infant, child, and adolescent on dialysis: 2014 update. Am J Kidney Dis. 2014;64(1):128–42.PubMedGoogle Scholar
  304. 304.
    Warady BA, Watkins SL, Fivush BA, Andreoli SP, Salusky I, Kohaut EC, Vonesh EF. Validation of PD Adequest 2.0 for pediatric dialysis patients. Pediatr Nephrol. 2001;16:205–11.PubMedGoogle Scholar
  305. 305.
    Warady BA, Schaefer F, Holloway M, Alexander S, Kandert M, Piraino B, Salusky I, Tranaeus A, Divino J, Honda M, Mujais S, Verrina E, International Society for Peritoneal Dialysis (ISPD) Advisory Committee on Peritonitis Management in Pediatric Patients. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int. 2000;20:610–24.PubMedGoogle Scholar
  306. 306.
    Warady BA. Sclerosing encapsulating peritonitis: what approach should be taken in children? Perit Dial Int. 2000;20:390–1.PubMedGoogle Scholar
  307. 307.
    Warady BA. Therapeutic camping for children with end-stage renal disease. Pediatr Nephrol. 1994;8:387–90.PubMedGoogle Scholar
  308. 308.
    Warchol S, Ziolkowska H, Roszkowska-Blaim M. Exit-site infection in children on peritoneal dialysis: comparison of two types of peritoneal catheters. Perit Dial Int. 2003;23:169–73.PubMedGoogle Scholar
  309. 309.
    Watson AR, Gartland C. Guidelines by an ad hoc European Committee for elective chronic peritoneal dialysis in pediatric patients. Perit Dial Int. 2001;21:240–4.PubMedGoogle Scholar
  310. 310.
    Watson AR. Psychosocial support for children and families requiring renal replacement therapy. Pediatr Nephrol. 2014;29(7):1169–74.PubMedGoogle Scholar
  311. 311.
    Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT, Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–9.PubMedGoogle Scholar
  312. 312.
    Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int. 2003;63 Suppl 84:S158–61.Google Scholar
  313. 313.
    Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J, Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66:408–18.PubMedGoogle Scholar
  314. 314.
    Witoski J, Jorres A, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Bender TO, Passlick-Deetjen J, Breborowicz A. Glucose degradation products in peritoneal dialysis fluids: do they harm ? Kidney Int. 2003;63 Suppl 84:S148–51.Google Scholar
  315. 315.
    Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis. 2000;36:811–9.PubMedGoogle Scholar
  316. 316.
    Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO. Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int. 2002;61:630–7.PubMedGoogle Scholar
  317. 317.
    Wood EG, Hand M, Briscoe DM, Donaldson LA, Yiu V, Harley FL, Warady BA, Ellis EN, North American Pediatric Renal Transplant Cooperative Study. Risk factors for mortality in infants and young children on dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2001;37:573–9.PubMedGoogle Scholar
  318. 318.
    Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, Tanaka Y, Kawamura K, Murai T, Kamiyama Y. Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis-free children. Perit Dial Int. 2001;21:180–5.PubMedGoogle Scholar
  319. 319.
    Zaloszyc A, Schaefer B, Schaefer F, Krid S, Salomon R, Niaudet P, Schmitt CP, Fischbach M. Hydration measurement by bioimpedance spectroscopy and blood pressure management in children on hemodialysis. Pediatr Nephrol. 2013;28(11):2169–77.PubMedGoogle Scholar
  320. 320.
    Zaritsky J, Warady BA. Peritoneal dialysis in infants and young children. Semin Nephrol. 2011;31(2):213–24.PubMedGoogle Scholar
  321. 321.
    Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int. 2003;63(1):298–3054.PubMedGoogle Scholar
  322. 322.
    Zhai Y, Bloch J, Homme M, Schaefer J, Hackert T, Phillipin B, Schwenger V, Schafer F, Schmitt CP. Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol. 2012;27(7):1165–77.PubMedGoogle Scholar
  323. 323.
    Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis. 2008;51:455–62.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Nephrology, Dialysis and Transplantation UnitGiannina Gaslini Children’s HospitalGenoaItaly
  2. 2.Centre for Pediatric and Adolescent MedicineHeidelbergGermany

Personalised recommendations